Nepal on Friday gave emergency authorisation to India’s Covid-19 vaccine COVAXIN, becoming only the third country to approve the shot, developed by Bharat Biotech and a state research institute. COVAXIN was shown to be 81% effective in an interim analysis of late-stage trial data on some 26,000 people in India. […]
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.